Relation of Cytogenetic Abnormalities and Clinical Outcome in Metastatic Melanoma
- 24 May 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (21), 1508-1511
- https://doi.org/10.1056/nejm199005243222107
Abstract
The value of chromosomal analysis is well established in human hematologic neoplasms. In contrast, the relation between chromosomal abnormalities and clinical outcome in solid tumors in humans has received little study. We undertook this study to determine whether chromosomal abnormalities could provide information on the survival of patients with malignant melanoma.This publication has 14 references indexed in Scilit:
- Report of the committee on structural chromosome changes in neoplasiaCytogenetic and Genome Research, 1989
- The involvement of 6p in melanomaCancer Genetics and Cytogenetics, 1986
- Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanomaSomatic Cell and Molecular Genetics, 1985
- The Relation of Oncogenesis and Cytogenetics in Leukemia and LymphomaAnnual Review of Medicine, 1985
- Cytogenetics of human malignant melanoma and premalignant lesionsCancer Genetics and Cytogenetics, 1984
- Prognostic Importance of Cytogenetic Abnormalities in Patients with Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1984
- Chromosome 6q involvement in human malignant melanomaCancer Genetics and Cytogenetics, 1983
- Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958